[go: up one dir, main page]

CL2013003066A1 - Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion - Google Patents

Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Info

Publication number
CL2013003066A1
CL2013003066A1 CL2013003066A CL2013003066A CL2013003066A1 CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1 CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1
Authority
CL
Chile
Prior art keywords
composition
wounds
mesenchymics
treatment
applying
Prior art date
Application number
CL2013003066A
Other languages
English (en)
Inventor
Alvarado Veronica Alejandra Palma
Merino Maria Rosa Bono
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Priority to CL2013003066A priority Critical patent/CL2013003066A1/es
Publication of CL2013003066A1 publication Critical patent/CL2013003066A1/es
Priority to PCT/CL2014/000055 priority patent/WO2015058318A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVEN´CIÓN PROPORCIONA UNA COMPOSICION PARA TRATAMIENTO DE HERIDAS PORQUE COMPRENDE MATRIZ SOPORTE Y CÉLULAS TRONCALESMESENQUIÁMICAS DE GELATINA DE WHARTON; METODO PARA TRATAR HERIDAS QUE COMPRENDE APLICAR DICHA COMPOSICION
CL2013003066A 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion CL2013003066A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
PCT/CL2014/000055 WO2015058318A1 (es) 2013-10-22 2014-10-20 Composición para acelerar o mejorar la cicatrización en heridas, y un método para acelerar o mejorar la cicatrización en heridas que comprende aplicar dicha composición

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Publications (1)

Publication Number Publication Date
CL2013003066A1 true CL2013003066A1 (es) 2014-07-25

Family

ID=52020872

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003066A CL2013003066A1 (es) 2013-10-22 2013-10-22 Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion

Country Status (2)

Country Link
CL (1) CL2013003066A1 (es)
WO (1) WO2015058318A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106310369A (zh) * 2016-09-29 2017-01-11 广州赛莱拉干细胞科技股份有限公司 一种组合物、含有该组合物的3d敷料及其制备方法
EP3456363B1 (en) * 2017-09-18 2020-11-04 Banc De Sang I Teixits Composition for regenerating bony tissue, method for preparation and use thereof
US10881693B2 (en) * 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
EP4132546A4 (en) 2020-04-07 2024-05-01 Combangio, Inc. SECRETOME DERIVED FROM LYOPHILIZED MESENCHYMAL STEM CELLS AND USES THEREOF
CN111760064A (zh) * 2020-08-25 2020-10-13 重庆大学附属肿瘤医院 一种用于治疗糖尿病足的敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012205269B2 (en) 2004-03-22 2015-08-27 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
US8709081B2 (en) * 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
KR101101321B1 (ko) 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
WO2010062297A1 (en) 2008-11-25 2010-06-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Regenerative tissue grafts and methods of making same
KR101109125B1 (ko) 2009-03-24 2012-02-15 한국과학기술연구원 줄기세포를 혈관세포로 분화시키는 방법 및 이를 이용한 생체 내 혈관신생 유도
WO2011023843A2 (es) * 2009-08-25 2011-03-03 Servicio Andaluz De Salud Elaboración de tejidos artificiales mediante ingeniería tisular utilizando biomateriales de fibrina y agarosa
SG182508A1 (en) * 2010-01-14 2012-08-30 Organogenesis Inc Bioengineered tissue constructs and methods for producing and using thereof
ITMI20100601A1 (it) * 2010-04-09 2011-10-10 Luisa Benassi "nuovo sostituto dermico e sua applicazione terapeutica"
WO2012131618A1 (en) 2011-03-30 2012-10-04 Stempeutics Research Private Limited A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof
WO2014027965A1 (en) * 2012-08-15 2014-02-20 National University Of Singapore Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells

Also Published As

Publication number Publication date
WO2015058318A1 (es) 2015-04-30

Similar Documents

Publication Publication Date Title
MX377544B (es) Composiciones topicas que comprenden un corticosteroide y un retinoide para tratar psoriasis.
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
MX370506B (es) Método para tratar trastorno de estrés post-traumático.
MX387753B (es) Proteínas de unión a calicreína en plasma y usos de las mismas para tratar el angioedema hereditario.
MX2018006578A (es) Formulaciones farmaceuticas topicas para tratar afecciones inflamatorias.
PT3661514T (pt) Mavacamten para utilização no tratamento da cardiomiopatia hipertrófica
MX2017010773A (es) Inhibidores de muerte programada 1 (pd-19)/ligando de muerte progamada 1 (pd-l1) para el tratamiento de cancer.
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
CL2018001258A1 (es) Métodos para tratar las condiciones asociadas con la activación del complemento dependiente de masp-2
CL2015002708A1 (es) Compuestos heterocíclicos y sus usos.
EP3092989C0 (en) BIODEGRADABLE MESENCHYMAL STEM CELL-HYDROGEL BASED OR NON-DEGRADABLE MESENCHYMAL STEM CELL-HYDROGEL BASED CARRIER COMPOSITION FOR SKIN REGENERATION OR WOUND HEALING
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
PL3615019T3 (pl) Modulator interakcji sestryna-gator2 do zastosowania w leczeniu depresji opornej na leczenie
MX2017016024A (es) Composiciones de nicotinamida ribósido y pteroestilbeno y métodos para el tratamiento de trastornos de la piel.
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
IL254863A0 (en) Formulation and process for modulating wound healing
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
CL2017002774A1 (es) Secuencias de uricasa mejorada y métodos de tratamiento
BR112015028193B8 (pt) Suporte para cicatrização de feridas
CR20140573A (es) Inhibidores del nampt
BR112013023227A2 (pt) método para tratar perda de circulação, e material de circulação perdida de gelificação (lcm)
MX386984B (es) Método para fabricar una barra que comprende antitranspirante.
CL2013003066A1 (es) Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
MX2015003701A (es) Composiciones para tratamiento.
MX2016006656A (es) Metodos para tratar rechazo mediado por anticuerpos en pacientes de trasplante de organos con inhibidor de c1-esterasa.